EGA

EUROPEAN GENERIC MEDICINES ASSOCIATION

Making Medicines Affordable
 
 

Biosimilar Medicines Take Centre Stage

ega

The 6th EGA Symposium on Biosimilar Medicines
has focussed fresh attention on this newest class of affordable pharmaceutical treatment.

Biosimilar medicines are here in Europe as a result of the regulatory pathway opened up through the EU Pharma Review. The guidelines are established, and registrations have been received and approved. The biosimlar medicines recently introduced in the EU are exected to generate savings of over €1.6 billion in Europe.

PRESS RELEASE: 24 April 2008

BIOSIMILAR MEDICINES – DEVELOPING MARKET PATHWAYS
    THAT BENEFIT PATIENTS IS A SHARED RESPONSIBILITY

Today at the 6th EGA Symposium on Biosimilar Medicines, Greg Perry congratulated the industry and EU medicines regulatory authorities today for further consolidating and developing the EU’s rigorously scientific “biosimilar thinking” during 2007.

Section Spotlight

Biosimilar Medicines

Introduction FAQ on Biosimilar Medicines EGA Handbook on Biosimilar Medicines Legal Framework Scientific Articles EGA Position Papers How Quickly Can EU Patients Benefit
  from the EU’s Lead on Biosimilar Medicines?

About Generic Medicines

Basic Notions | The Science| The Economics | IP... Fact Sheets on Generic Medicines

14th Annual EGA Conference

Latest News

EGA PRESENTATION: April 2008 Latest EU Developments in GMP Affecting Starting Materials

• Julie Maréchal, Sr Manager Regulatory Affairs, EGA
EU Commission Survey & EMEA Inspectorate Action Plan (API GMP) | EU Legislative Proposal | Revision of the EU GMP Guide | Impact of ICH Quality Related Topics     More...

EGA PUBLICATION: March 2008 EGA CONFERENCE highlights: “Working Together for Generic Medicines”

“The EGA and EU Medicines Authorities Vow Joint Effort to Develop Greater Regulatory Efficiency for Generic Medicines”    More...

EGA PRESENTATION: March 2008 Challenges and Opportunities for Generic Medicines Companies

• Elke Grooten, Director Pharmaceutical Policy, EGA
Presentation to the DIA Conference | March 2008, Barcelona

EGA Events

Paris 14th EGA
Annual Conference
Paris | 2-3 June 2008

Paris AFSSAPS—EGA
Information Day
Paris | 4 June 2008
 
Register Now!
Places are Limited

Geneva 11th IGPA
Annual Conference
Geneva | 8-10 Dec 2008

 

“The EGA is the official representative body of the European generic and biosimilar pharmaceutical industry, which is at the forefront of providing high-quality
affordable medicines to millions of Europeans and stimulating competitiveness and innovation in the pharmaceutical sector.”